Neurological involvement associated with COVID-19 disease: a study on psychosocial factors.
COVID-19
HADS
Neurological manifestation
PSQI
WHODAS-12
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
21
12
2021
accepted:
17
01
2022
pubmed:
23
1
2022
medline:
16
3
2022
entrez:
22
1
2022
Statut:
ppublish
Résumé
Several people affected by COVID-19 experienced neurological manifestations, altered sleep quality, mood disorders, and disability following hospitalization for a long time. To explore the impact of different neurological symptoms on sleep quality, mood, and disability in a consecutive series of patients previously hospitalized for COVID-19 disease. We evaluated 83 patients with COVID-19 around 3 months after hospital discharge. They were divided into 3 groups according to their neurological involvement (i.e., mild, unspecific, or no neurological involvement). Socio-demographic, clinical data, disability level, emotional distress, and sleep quality were collected and compared between the three groups. We found that higher disability, depressive symptoms, and lower sleep quality in patients with mild neurological involvement compared to patients with unspecific and no neurological involvement. Differences between groups were also found for clinical variables related to COVID-19 severity. After 3 months from hospital discharge, patients with more severe COVID-19 and mild neurological involvement experienced more psychosocial alterations than patients with unspecific or no neurological involvement. Both COVID-19 and neurological manifestations' severity should be considered in the clinical settings to plain tailored interventions for patients recovering from COVID-19.
Sections du résumé
BACKGROUND
BACKGROUND
Several people affected by COVID-19 experienced neurological manifestations, altered sleep quality, mood disorders, and disability following hospitalization for a long time.
OBJECTIVE
OBJECTIVE
To explore the impact of different neurological symptoms on sleep quality, mood, and disability in a consecutive series of patients previously hospitalized for COVID-19 disease.
METHODS
METHODS
We evaluated 83 patients with COVID-19 around 3 months after hospital discharge. They were divided into 3 groups according to their neurological involvement (i.e., mild, unspecific, or no neurological involvement). Socio-demographic, clinical data, disability level, emotional distress, and sleep quality were collected and compared between the three groups.
RESULTS
RESULTS
We found that higher disability, depressive symptoms, and lower sleep quality in patients with mild neurological involvement compared to patients with unspecific and no neurological involvement. Differences between groups were also found for clinical variables related to COVID-19 severity.
CONCLUSION
CONCLUSIONS
After 3 months from hospital discharge, patients with more severe COVID-19 and mild neurological involvement experienced more psychosocial alterations than patients with unspecific or no neurological involvement. Both COVID-19 and neurological manifestations' severity should be considered in the clinical settings to plain tailored interventions for patients recovering from COVID-19.
Identifiants
pubmed: 35064346
doi: 10.1007/s10072-022-05907-1
pii: 10.1007/s10072-022-05907-1
pmc: PMC8782679
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2187-2193Informations de copyright
© 2022. Fondazione Società Italiana di Neurologia.
Références
Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585
doi: 10.1001/jama.2020.1585
pubmed: 32031570
pmcid: 7042881
Werner C, Scullen T, Mathkour M et al (2020) Neurological impact of coronavirus disease of 2019: practical considerations for the neuroscience community. World Neurosurg 139:344–354. https://doi.org/10.1016/j.wneu.2020.04.222
doi: 10.1016/j.wneu.2020.04.222
pubmed: 32387786
pmcid: 7202815
Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):683–690. https://doi.org/10.1001/jamaneurol.2020.1127
doi: 10.1001/jamaneurol.2020.1127
pubmed: 32275288
Li Y-C, Bai W-Z, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92(6):552–555. https://doi.org/10.1002/jmv.25728
doi: 10.1002/jmv.25728
pubmed: 32104915
Helms J, Kremer S, Merdji H et al (2020) Neurologic Features in severe SARS-CoV-2 infection. N Engl J Med 382(23):2268–2270. https://doi.org/10.1056/NEJMc2008597
doi: 10.1056/NEJMc2008597
pubmed: 32294339
Niazkar HR, Zibaee B, Nasimi A, Bahri N (2020) The neurological manifestations of COVID-19: a review article. Neurol Sci 41(7):1667–1671. https://doi.org/10.1007/s10072-020-04486-3
doi: 10.1007/s10072-020-04486-3
pubmed: 32483687
Gibson PG, Qin L, Puah SH (2020) COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust 213(2):54–56. https://doi.org/10.5694/mja2.50674
doi: 10.5694/mja2.50674
pubmed: 32572965
Pilotto A, Cristillo V, Piccinelli SC et al (2021) Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci 398(10302):725. https://doi.org/10.1016/S0140-6736(21)01900-0
doi: 10.1016/S0140-6736(21)01900-0
Lancet T (2021) Understanding long COVID: a modern medical challenge. Lancet (London, England) 398(10302):725. https://doi.org/10.1016/S0140-6736(21)01900-0
doi: 10.1016/S0140-6736(21)01900-0
Huang C, Huang L, Wang Y et al (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England) 397(10270):220–232. https://doi.org/10.1016/S0140-6736(20)32656-8
doi: 10.1016/S0140-6736(20)32656-8
Akıncı T, Melek BH (2021) Relationship between sleep quality and the psychological status of patients hospitalised with COVID-19. Sleep Med 80:167–170. https://doi.org/10.1016/j.sleep.2021.01.034
doi: 10.1016/j.sleep.2021.01.034
pubmed: 33601228
pmcid: 7842153
Marelli S, Castelnuovo A, Somma A et al (2021) Impact of COVID-19 lockdown on sleep quality in university students and administration staff. J Neurol 268(1):8–15. https://doi.org/10.1007/s00415-020-10056-6
doi: 10.1007/s00415-020-10056-6
pubmed: 32654065
Liu K, Chen Y, Wu D, Lin R, Wang Z, Pan L (2020) Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract 39:101132. https://doi.org/10.1016/j.ctcp.2020.101132
doi: 10.1016/j.ctcp.2020.101132
pubmed: 32379667
pmcid: 7102525
Vitale JA, Perazzo P, Silingardi M, Biffi M, Banfi G, Negrini F (2020) Is disruption of sleep quality a consequence of severe Covid-19 infection? A case-series examination. Chronobiol Int 37(7):1110–1114. https://doi.org/10.1080/07420528.2020.1775241
doi: 10.1080/07420528.2020.1775241
pubmed: 32573293
Dai LL, Wang X, Jiang TC et al (2020) Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China. PLoS One 5(8):e0238416. https://doi.org/10.1371/journal.pone.0238416
Poyraz BÇ, Poyraz CA, Olgun Y et al (2021) Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. https://doi.org/10.1016/j.psychres.2020.113604
doi: 10.1016/j.psychres.2020.113604
pubmed: 33296818
Henneghan AM, Lewis KA, Gill E et al (2021) Describing cognitive function and psychosocial outcomes of COVID-19 survivors: a cross-sectional analysis. J Am Assoc Nurse Pract. https://doi.org/10.1097/JXX.0000000000000647
doi: 10.1097/JXX.0000000000000647
pubmed: 34469360
Zhang X, Wang F, Shen Y et al (2021) Symptoms and health outcomes among survivors of covid-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw open 4(9):e2127403. https://doi.org/10.1001/jamanetworkopen.2021.27403
doi: 10.1001/jamanetworkopen.2021.27403
pubmed: 34586367
pmcid: 8482055
Fleischer M, Köhrmann M, Dolff S et al (2021) Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. Ther Adv Neurol Disord 14:1756286421993701. https://doi.org/10.1177/1756286421993701
doi: 10.1177/1756286421993701
pubmed: 33737955
pmcid: 7934032
Piva S, Filippini M, Turla F et al (2020) Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J Crit Care 58:29–33. https://doi.org/10.1016/j.jcrc.2020.04.004
doi: 10.1016/j.jcrc.2020.04.004
pubmed: 32330817
pmcid: 7194649
Linn BS, Linn MW, Gurel LEE (1968) Cumulative illness rating scale. J Am Geriatr Soc 16(5):622–626
doi: 10.1111/j.1532-5415.1968.tb02103.x
pubmed: 5646906
Santangelo G, Siciliano M, Pedone R et al (2015) Normative data for the Montreal cognitive assessment in an Italian population sample. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 36(4):585–591. https://doi.org/10.1007/s10072-014-1995-y
doi: 10.1007/s10072-014-1995-y
Costantini M, Musso M, Viterbori P et al (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the hospital anxiety and depression scale. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 7(3):121–127. https://doi.org/10.1007/s005200050241
doi: 10.1007/s005200050241
Andrews G, Kemp A, Sunderland M, Von Korff M, Ustun TB (2009) Normative data for the 12 item who disability assessment schedule 2.0. PLoS One 4(12):e8343. https://doi.org/10.1371/journal.pone.0008343
Curcio G, Tempesta D, Scarlata S et al (2013) Validity of the Italian version of the Pittsburgh Sleep Quality Index (PSQI). Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 34(4):511–519. https://doi.org/10.1007/s10072-012-1085-y
doi: 10.1007/s10072-012-1085-y
Del Rio C, Collins LF, Malani P (2020) Long-term health consequences of COVID-19. JAMA 324(17):1723–1724. https://doi.org/10.1001/jama.2020.19719
doi: 10.1001/jama.2020.19719
pubmed: 33031513
pmcid: 8019677
Mazza MG, De Lorenzo R, Conte C et al (2020) Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun 89:594–600. https://doi.org/10.1016/j.bbi.2020.07.037
doi: 10.1016/j.bbi.2020.07.037
pubmed: 32738287
pmcid: 7390748
Matalon N, Dorman-Ilan S, Hasson-Ohayon I et al (2021) Trajectories of post-traumatic stress symptoms, anxiety, and depression in hospitalized COVID-19 patients: a one-month follow-up. J Psychosom Res 143:110399. https://doi.org/10.1016/j.jpsychores.2021.110399
doi: 10.1016/j.jpsychores.2021.110399
pubmed: 33618149
pmcid: 7885629
Boardman HF, Thomas E, Millson DS, Croft PR (2005) Psychological, sleep, lifestyle, and comorbid associations with headache. Headache 45(6):657–669. https://doi.org/10.1111/j.1526-4610.2005.05133.x
doi: 10.1111/j.1526-4610.2005.05133.x
pubmed: 15953298
Sugaya N, Arai M, Goto F (2017) The effect of sleep disturbance in patients with chronic dizziness. Acta Otolaryngol 137(1):47–52. https://doi.org/10.1080/00016489.2016.1213418
doi: 10.1080/00016489.2016.1213418
pubmed: 27551863
Leonardi M, Padovani A, McArthur JC (2020) Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol 267(6):1573–1576. https://doi.org/10.1007/s00415-020-09896-z
doi: 10.1007/s00415-020-09896-z
pubmed: 32436101
pmcid: 7238392
Kremer S, Lersy F, de Sèze J et al (2020) Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology 297(2):E242–E251. https://doi.org/10.1148/radiol.2020202222
doi: 10.1148/radiol.2020202222
pubmed: 32544034